SME · BSE SMEListed

Himalaya Nutravedics India Ltd. IPO: dates, price band, lot size, objects of the issue

Get analyst updates on this IPO

Analyst updates come by email.

What changed since listing, from SEBI-registered research analysts.

By continuing you agree to the Terms and Privacy policy

Updated Tue 17 Nov 2026, 7:15 am IST · Source: RHP dated Tue 15 Sep 2026

Bid dates
Tue 22 Sep 2026 to Thu 24 Sep 2026
Listing date
Tue 29 Sep 2026
Issue price
₹106 per share

Listed on BSE on Tue 29 Sep 2026.

Listing price ₹118

Opening price on BSE on the listing day (BSE daily price file for Tue 29 Sep 2026)

This page is now frozen. Facts stay as filed; the quote is on the exchange.

Key facts

Issue price
₹106 per share
groww.in, as of Mon 16 Nov 2026
Lot size
Not stated in the RHP
RHP dated Tue 15 Sep 2026
Lot amount at the upper band
Not stated in the RHP
RHP dated Tue 15 Sep 2026
Issue size at the upper band
₹26.50 crore
Computed from the issue price (groww.in, as of Mon 16 Nov 2026)
Fresh issue
24,99,600 shares (Amount not stated in the RHP)
RHP dated Tue 15 Sep 2026, page 1
Offer for sale
None
RHP dated Tue 15 Sep 2026, page 1
Bid dates
Tue 22 Sep 2026 to Thu 24 Sep 2026
RHP dated Tue 15 Sep 2026, page 82
Listing date
Tue 29 Sep 2026
BSE daily price file for Tue 29 Sep 2026
Anchor lock-in ends
Set after bidding
RHP dated Tue 15 Sep 2026
Risk factors
71
RHP dated Tue 15 Sep 2026, page 64

Timeline (IST)

  1. OpensTue 22 Sep 2026, 10:00 am IST confirmedRHP dated Tue 15 Sep 2026, page 82
  2. ClosesThu 24 Sep 2026 confirmedRHP dated Tue 15 Sep 2026, page 82
  3. UPI mandate cut-offThu 24 Sep 2026, 5:00 pm IST confirmedRHP dated Tue 15 Sep 2026, page 1
  4. AllotmentFri 25 Sep 2026 confirmedRHP dated Tue 15 Sep 2026, page 327
  5. Refund and unblockMon 28 Sep 2026 confirmedRHP dated Tue 15 Sep 2026, page 327
  6. Shares to dematMon 28 Sep 2026 confirmedRHP dated Tue 15 Sep 2026, page 327
  7. ListingTue 29 Sep 2026 confirmedBSE daily price file for Tue 29 Sep 2026

Objects of the issue

ObjectAmount
Funding Working Capital Requirements₹13.75 crore
Investment in Branding, Digital Marketing and Sales Expansion₹7.50 crore
General Corporate Purposes^Not stated in the RHP
TotalNot stated in the RHP

RHP dated Tue 15 Sep 2026, page 105

Company and promoters

As described in the RHP

Our Company, Himalaya Nutravedics India Limited (the “Company”), is engaged in the manufacturing, marketing and distribution of Ayurvedic and Nutraceutical formulations in India and also undertakes third-party contract manufacturing for other Ayurvedic and Nutraceutical companies.

RHP dated Tue 15 Sep 2026, page 172

Promoters

  • 4 individual promoters

RHP dated Tue 15 Sep 2026, page 231

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group95.14%Not stated in the RHP

RHP dated Tue 15 Sep 2026, page 99

Financials (restated)

ItemMarch 31, 2026March 31, 2025March 31, 2024
Revenue from operations₹43.07 crore₹21.00 crore₹14.43 crore
Profit after tax₹7.39 crore₹2.23 crore₹42.60 lakh
Net worth₹16.38 crore₹6.75 crore₹1.34 crore
Total borrowings₹5.13 crore₹1.76 crore₹3.24 crore

RHP dated Tue 15 Sep 2026, page 69

SME issue facts

  • The present Public Issue of up to 24,99,600 Equity Shares has been authorized by a resolution of the Board (RHP dated Tue 15 Sep 2026, page 324)
  • The face value of each Equity Share is ₹10/- and the Issue Price at the lower end of the Price Band is ₹ [●] per (RHP dated Tue 15 Sep 2026, page 325)
  • The trading of the Equity Shares will happen in the minimum contract size of [●] Equity Shares and the same (RHP dated Tue 15 Sep 2026, page 326)
  • In accordance with Regulation 268 of SEBI (ICDR) Regulations, 2018 the minimum number of allottees in the (RHP dated Tue 15 Sep 2026, page 326)

Peer comparison (as in the RHP)

Name of the companyFace valueRevenue from Operations (₹ in Lakhs)EPS (Basic) (₹)EPS (Diluted) (₹)P/E*Return on Net Worth (%)Net Worth (₹ in Lakhs)Net Asset Value Per Equity Share (₹)
Himalaya Nutravedics India Limited104,306.7512.0512.05[●]^^45.121,637.6126.70
Jeena Sikho Lifecare Limited#280,136.3917.8417.8128.7527.6746,740.0537.60
Sandu Pharmaceuticals Limited#106,993.451.831.8320.622.534,367.3345.21

Reproduced from the RHP dated Tue 15 Sep 2026, page 125; InsightPier adds no figures

Risk factors

71 total
  1. Most revenue comes from Ayurvedic products, so lower demand for them would hurt the business (RHP page 33)
  2. A few key customers account for most revenue (RHP page 33)
  3. Profit may fall when the Section 80-IAC tax benefit ends (RHP page 35)
  4. All manufacturing is at one facility in Hyderabad (RHP page 35)
  5. The company's trademark applications are opposed and its brand may not be protected (RHP page 31)

All 71 risk factors, RHP pages 30 to 65

Offer document

Allotment and bids

Registrar to the issue: Kfin Technologies Limited.

Allotment status is on the registrar's site, from Fri 25 Sep 2026. Pick "Himalaya Nutravedics India Ltd." from the issue list there.

Subscription (final)

CategoryShares offeredShares bid forTimes subscribed
Overall––2.41×

ipocentral.in and ipowatch.in, as of Tue 17 Nov 2026

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts